Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879840 · ClinicalTrials.gov registry record
Assessment of Screening Modalities for Gynecologic Cancers
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 118
- Enrollment target
NCT00879840: Completed study, sponsored by National Cancer Institute (NCI).
NCT00879840 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00879840 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
Background: * Endometrial and ovarian cancers are, respectively, the fourth and eighth most common cancers among women in the United States. Although some routine Pap tests may detect the presence of cancer cells, there are no convincing early detection approaches for either cancer. Better methods of detection are needed. * Two possible methods for cancer detection involve samples taken with a tampon or a special kind of brush, called a Tao brush. Researchers would like to know more about how well these methods work. Objectives: * To assess the quality of DNA collected by the tampon and Tao brush sampling methods. * To detect genetic markers in collected DNA and determine if these markers are related to an individual s cancer status. Eligibility: * Women age 45 years and older with confirmed or suspected endometrial or ovarian cancer, who will be having surgery. * A control group of postmenopausal women having surgery for benign gynecological conditions will be included. Design: * Shortly before hysterectomy or more extensive procedures to treat either cancer or the benign condition: * A tampon will be inserted into the vagina to collect cell samples, and removed after 30 minutes. * After the tampon is removed, the cervix will be swabbed with the Tao brush to collect cell samples. * Following the hysterectomy, samples of healthy and cancerous tissue will be taken, and tested by researchers.
Primary Outcome
Histologically confirmed endometrial or ovarian cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2009-04-09 |
| Est. Completion | 2020-11-16 |
What the finished NCT00879840 record still lists
NCT00879840 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00879840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00879840 about?
NCT00879840 is a clinical study titled "Assessment of Screening Modalities for Gynecologic Cancers". Background: * Endometrial and ovarian cancers are, respectively, the fourth and eighth most common cancers among women in the United States. Although some routine Pap tests may detect the presence of cancer cells, there are no convincing early detection approaches for either cancer. Better methods ...
What is the current status of trial NCT00879840?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2009-04-09. Estimated completion is 2020-11-16.
Who is sponsoring clinical trial NCT00879840?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI